期刊文献+

益气温阳活血方对早期心力衰竭大鼠血管紧张素Ⅱ和醛固酮的影响 被引量:8

Effects of decoction of yiqiwenyanghuoxue on Ang Ⅱ and ALD in rats with early heart failure
下载PDF
导出
摘要 目的探讨中药复方益气温阳活血方对早期心力衰竭大鼠血管紧张素Ⅱ(AngⅡ)、醛固酮(ALD)的作用机制。方法以阿霉素尾静脉注射造模;超声检测评价其心功能、应用放射免疫法检测AngⅡ、ALD浓度、以RT-PCR法及W estern印迹法检测过氧化物酶体增殖物激活受体γ(PPARγ)mRNA及蛋白质表达水平在益气温阳活血方治疗前后的变化。结果随着心力衰竭的加重、心室重构的形成,模型大鼠AngⅡ、ALD含量进行性升高,而PPARγmRNA与蛋白质的表达水平则进性降低。益气温阳活血方在心力衰竭的早期即可减少AngⅡ、ALD含量及上调PPARγmR-NA与蛋白质的表达水平。结论 AngⅡ、ALD可作为早期心力衰竭预警标志物;益气温阳活血方在心力衰竭早期可通过PPARγ信号通路调节AngⅡ、ALD的表达,防止心室重塑,改善心脏功能。 Objective To investigate the effects of decoction of yiqiwenyanghuoxue on Ang Ⅱ and aldosterone(ALD) in rats with early heart failure.Methods Model rats with chronic heart failure(CHF)were injected with Adriamycin and treated by decoction of yiqiwenyanghuoxue,then AngⅡ and ALD levels were detected by radioimmunity.PPARγ mRNA were detected by RT-PCR and protein by Western-blot.Results Compared to the control group,Ang Ⅱ and ALD levels were significantly higher,but PPARγ at mRNA and protein levels were significantly lower in CHF groups.Yiqiwenyanghuoxue decoction could improve the above changes.Conclusions AngⅡ,ALD can be the predictors in early heart failure.Decoction of yiqiwenyanghuoxue can prevent myocardial remodeling and improve heart function through PPARγ regulating AngⅡand ALD levels.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2011年第13期2472-2474,共3页 Chinese Journal of Gerontology
基金 贵州省教育厅自然科学研究项目(黔科教2008028号) 贵州省中药管理局项目(黔中医药发〔2009〕79号) 贵州省科技计划项目(黔科合SY〔2010〕3121号) 贵阳市科学技术计划项目(〔2010〕筑科农合同字第1-社-37号)
关键词 早期心力衰竭 AngⅡ ALD PPARΓ 益气温阳活血方 Early heart failure AngⅡ ALD PPARγ Decoction of yiqiwenyanghuoxue
  • 相关文献

参考文献7

二级参考文献55

  • 1TAOZe-wei,HUANGYuan-wei,XIAQiang,XUQi-wen.Combined effects of ramipril and angiotensin Ⅱ receptor blocker TCV116 on rat congestive heart failure after myocardial infarction[J].Chinese Medical Journal,2005(2):146-154. 被引量:19
  • 2[1]VIDAL-PUIG AJ,CONSIDINE RV,JIMENEZ-LINAN M,et al.Peroxisome proliferator-activated receptor gene expression in human tissues.Effects of obesity,weight loss,and regulation by insulin and glucocorticoids[J].J Clin Invest,1997,99(10):2416-2422.
  • 3[2]GHANIM H,GARG R,ALJADA A,et al.Suppression of nuclear factor-kappa B and stimulation of inhibitor kappa B by troglitazone:evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese[J].J Clin Endocrinol Metab,2001,86(3):1306-1312.
  • 4[3]DUEZ H,FRUCHART JC,STAELS B.PPARS in inflammation,atherosclerosis and thrombosis[J].J Cardiovasc Risk,2001,8(4):187-194.
  • 5[4]DAYNES RA,JONES DC.Emerging roles of PPARs in inflammation and immunity[J].Nat Rev Immunol,2002,2(10):748-759.
  • 6[5]LI AC,BROWN KK,SILVESTRE MJ,et al.Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice[J].J Clin Invest,2000,106(4):523-531.
  • 7[6]COLLINS AR,MEEHAN WP,KINTSCHER U,et al.Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice[J].Arterioscler Thromb Vasc Biol,2001,21(3):365-371.
  • 8[7]SIDHU JS,COWAN D,KASKI JC.The effects of rosiglitazone,a peroxisome proliferator-activated receptor-gamma agonist,on markers of endothelial cell activation,Creactive protein,and fibrinogen levels in non-diabetic coronary artery disease patients[J].J Am Coll Cardiol,2003,42(10):1757-1763.
  • 9[8]IKEDA Y,SUGAWARA A,TANIYAMA Y,et al.Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator -activated receptor gamma in macrophages via an interaction with NRF2[J].J Biol Chem,2000,275(42):33142-33150.
  • 10[9]SUGAWARA A,URUNO A,KUDO M,et al.Transcription Suppression of Thromboxane Receptor Gene by Peroxisome Proliferator-activated Receptor-gamma via an Interaction with Sp1 in Vascular Smooth Muscle Cells[J].J Biol.Chem.,2002,277(12):9676-9683.

共引文献29

同被引文献139

引证文献8

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部